Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketwatch.com - Sumitomo Dainippon Pharma FY Net Y106.87B Vs Net Y23.63B
Sumitomo Dainippon Pharma FY Net Y106.87B Vs Net Y23.63B
MarketWatch

Sumitomo Dainippon Pharma Co. Ltd. (4506.TO) Japan Year Ended March 31 GROUP 2026 2025 Revenue Y453.29 bln Y398.83 bln Operating Profit Y107.34 bln Y28.80 bln Net Profit Y106.87 bln Y23.63 bln Per share Earnings Y268.99 Y59.49 Results are based on…

boston.com - Associated Press - Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
Boston.com

WASHINGTON (AP) — The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activists, vaping lobbyists and other allies of…

fool.com - Jonathan Ponciano - What to Know About This Fund's Sale of a Pharma Stock Up 56% in a Year
What to Know About This Fund's Sale of a Pharma Stock Up 56% in a Year
The Motley Fool

On May 12, 2026, Quantedge Capital disclosed in an SEC filing that it sold out its entire stake in Supernus Pharmaceuticals (SUPN +2.24%) during the first quarter, with an estimated transaction value of $4.56 million based on quarterly average…

seekingalpha.com - SA Transcript Insights Editor - OptimizeRx forecasts $95M-$100M 2026 revenue while maintaining $21M-$25M adjusted EBITDA amid pharma MFN disruption (NASDAQ:OPRX)
OptimizeRx forecasts $95M-$100M 2026 revenue while maintaining $21M-$25M adjusted EBITDA amid pharma MFN disruption (NASDAQ:OPRX)
Seeking Alpha

Due to continued softness in contracted revenue linked to MFN pricing disruption, more cautious customer budgets, shorter contract durations, and disruption at one major client. DSP integration is seen as a major strategic shift, enabling access to…

marketbeat.com - HC Wainwright Raises Earnings Estimates for BridgeBio Pharma
HC Wainwright Raises Earnings Estimates for BridgeBio Pharma
MarketBeat

BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - HC Wainwright increased their Q2 2026 earnings per share estimates for shares of BridgeBio Pharma in a report issued on Monday…

mymotherlode.com - AP News - Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
myMotherLode.com

Published May 12, 2026 11:14 am WASHINGTON (AP) — The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activists…

marketbeat.com - BridgeBio Pharma Touts Attruby Blockbuster Path, 3 Potential Pipeline Launches
BridgeBio Pharma Touts Attruby Blockbuster Path, 3 Potential Pipeline Launches
MarketBeat

BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope BridgeBio Pharma NASDAQ: BBIO executives used a BofA healthcare conference appearance in Las Vegas to reiterate confidence in the commercial trajectory of Attruby and outline…

rediff.com - Rediff News - Stock markets snap four days of losses
Stock markets snap four days of losses
Rediff.com

Benchmark equity indices Sensex and Nifty ended marginally higher on Wednesday, snapping their four-day losing streak, as elevated crude oil prices and persistent geopolitical uncertainties restricted the upside. The 30-share BSE Sensex rose 49.74…

thehill.com - Nathaniel Weixel - FDA Commissioner Marty Makary resigns
FDA Commissioner Marty Makary resigns
The Hill

Food and Drug Administration (FDA) Commissioner Marty Makary officially stepped down from his role on Tuesday. Makary managed to anger just about every constituency, from the pharma and biotech industries to the anti-abortion movement, but the end…

rediff.com - Nandita Malik - Indian Stock Markets Rebound: Sensex, Nifty Edge Up
Indian Stock Markets Rebound: Sensex, Nifty Edge Up
Rediff.com

Indian benchmark equity indices, Sensex and Nifty, managed a marginal rebound, ending a four-day losing streak, as investors navigated elevated crude oil prices and persistent geopolitical uncertainties, signalling a cautious yet stable market…

republicworld.com - Shourya Jha - Market Volatility: Sensex and Nifty Stagnant; Banking Drags as Titan Leads Sectoral Sell-off
Market Volatility: Sensex and Nifty Stagnant; Banking Drags as Titan Leads Sectoral Sell-off
Republic World

The NSE Nifty 50 opened at 23,362.45 and hit an intraday high of 23,503.80 before settling near 23,399.45. Despite the marginal 0.09% gain, the advance-decline ratio favored bears, with nearly 2,711 stocks declining against 584 advances on the…

seekingalpha.com - SA Transcripts - Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha

Teva Pharmaceutical Industries Limited (TEVA) Bank of America Global Healthcare Conference 2026 May 12, 2026 12:20 PM EDT Eric Hughes - Executive VP of Global R&D and Chief Medical Officer Jason Gerberry - BofA Securities, Research Division BofA…

cityandstateny.com - Jeremy Zellner - Opinion: Big Pharma is lying about 340B, and New Yorkers are the ones who will pay
Opinion: Big Pharma is lying about 340B, and New Yorkers are the ones who will pay
City & State New York

Something is happening in New York this year that should bother anyone who cares about affordability and basic fairness. On one side are community health centers – organizations that stretch every dollar to keep their doors open and deliver…

kare11.com - Danny Spewak - In battle between hospitals and pharmaceutical industry, rural Minnesota hospitals say they need legislative help
In battle between hospitals and pharmaceutical industry, rural Minnesota hospitals say they need legislative help
kare11.com

ST PAUL, Minn. — Rural hospital executives rallied at the state capitol on Tuesday, begging lawmakers to pass a bill in the session's final days that they say will help them stay afloat financially. The legislation would add protections…

thehindu.com - Pti - Stock markets snap four days of losses; end marginally higher
Stock markets snap four days of losses; end marginally higher
The Hindu

Benchmark equity indices Sensex and Nifty ended marginally higher on Wednesday (May 13, 2026), snapping their four-day losing streak, as elevated crude oil prices and persistent geopolitical uncertainties restricted the upside. The 30-share BSE…

Receive a Daily briefing on Pharma Industry News

Get Started